Using an external tracking device can lead to super-resolution that can potentially improve neurological disorder detection.
A new PET imaging technique uses the head motions that usually cause problems during brain imaging to produce scans that have the potential to detect neurological disorders, including Alzheimer’s disease, at their earliest stages.
In a poster presented during the Society of Nuclear Medicine and Molecular Imaging 2021 Annual Meeting, investigators from the Gordon Center for Medical Imaging in Boston showed how combining PET with an external motion tracking device can produce highly detailed brain images. It’s a process dubbed super-resolution, they said, and it could lead to faster diagnosis and treatment.
For more SNMMI 2021 coverage, click here.
Typically, unwanted patient movements during scanning degrades image quality. But, the team, led by Yanis Chemli, MSc, Ph.D. candidate at the Gordon Center, determined focusing on and measuring those movements can actually improve resolution.
“This work shows that one can obtain PET images with a resolution that outperforms the scanner’s resolution by making use, counterintuitively perhaps, of usually undesired patient motion,” Chemli said. “Our technique not only compensates for the negative effects of head motion on PET image quality, but it also leverages the increased sampling information associated with imaging of moving targets to enhance the effective PET resolution.”
For the study, the team performed moving phantom and non-human primate experiments on a PET scanner with an external motion tracking device that continuously captured extremely precise measurements of head movements. They also completed static reference PET acquisitions without induced movements.
The researchers combined data from the PET scanner and the external tracker, and they recovered PET images that had noticeably higher resolution than what the static reference scans were able to achieve.
Although this super-resolution technique has only been tested in pre-clinical environments, work is underway to extend it to human patients. Ultimately, Chemli said, the technique could have a significant impact on brain disorders, specifically Alzheimer’s.
“Alzheimer’s disease is characterized by the presence of tangles composed of tau protein. These tangles start accumulating very early on in Alzheimer’s disease – sometimes decades before symptoms – in very small regions of the brain,” he said. “The better we can image these small structures in the brain, the earlier we may be able to diagnose and, perhaps in the future, treat Alzheimer’s disease.”
For more coverage based on industry expert insights and research, subscribe to the Diagnostic Imaging e-Newsletter here.
Study Assesses Lung CT-Based AI Models for Predicting Interstitial Lung Abnormality
September 6th 2024A machine-learning-based model demonstrated an 87 percent area under the curve and a 90 percent specificity rate for predicting interstitial lung abnormality on CT scans, according to new research.
What a Prospective CT Study Reveals About Adjunctive AI for Triage of Intracranial Hemorrhages
September 4th 2024Adjunctive AI showed no difference in accuracy than unassisted radiologists for intracranial hemorrhage (ICH) detection and had a slightly longer mean report turnaround time for ICH-positive cases, according to newly published prospective research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
New Study Identifies Key Computed Tomography Findings for Post-Op Recurrence of Pancreatic Cancer
August 22nd 2024For patients who had post-op recurrence after a Whipple procedure for pancreatic ductal adenocarcinoma (PDAC), between 80 to 86 percent of follow-up CT exams revealed new or increased soft tissue.